Trained Therapeutics Discovery, Inc. — Form D/A
Trained Therapeutics Discovery, Inc. of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2021-02-10. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-02-10
- Form: D/A
- Accession: 0001811734-21-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Minimum investment: $10K
- Investors: 45
- Date of first sale: 2019-07-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369493
Issuer
- Name: Trained Therapeutics Discovery, Inc.
- CIK: 0001811734
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2223 W. JEFFERSON BLVD., DALLAS, TX, 75208
- Phone: 214-946-8000
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Leighton Durham III | Executive Officer | Dallas, TX |
| Leighton Durham III | Promoter | Dallas, TX |
Other filings by this issuer (1)
More